63624-28-2Relevant articles and documents
Dihydroxyphenyl Sulfonylisoindoline Derivatives
-
Paragraph 058; 064; 0116, (2018/06/12)
Provided are compounds that are inhibitors of pyruvate dehydrogenase kinase (PDK), and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.
Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
-
, (2008/06/13)
The invention relates to compounds of formula: and to solvates and/or hydrates thereof, with affinity for and selectivity towards the V1b receptors or both the V1b and V1a receptors of arginine-vasopressin. The invention also relates to a process for preparing them, to the intermediate compounds of formula (II) which are useful for preparing them, to pharmaceutical compositions containing them and to their use for preparing medicinal products.
Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane
Jacob III,Anderson III,Meshul,Shulgin,Castagnoli Jr.
, p. 1235 - 1239 (2007/10/06)
Regiospecific syntheses of the three monomethylthio analogues of 1-(2,4,5- trimethoxyphenyl)-2-aminopropane are described. The three isomeric amines were evaluated for potential psychotomimetic potency using the rabbit hyperthermia assay. Enantiomeric com